Senzime AB (publ)
STO:SEZI
Senzime AB (publ)
STO:SEZI
Price:
4.2
SEK
Market Cap:
kr660.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Senzime AB (publ)
STO:SEZI
|
SE |
|
Dolat Algotech Ltd
NSE:DOLATALGO
|
IN |
|
M
|
Maagh Advertising & Marketing Services Ltd
BSE:543624
|
IN |
|
Mach Natural Resources LP
NYSE:MNR
|
US |
|
Lendlease Global Commercial REIT
SGX:JYEU
|
SG |
|
Q
|
Qingmu Digital Technology Co Ltd
SZSE:301110
|
CN |
|
V
|
Victory Supermarket Chain Ltd
TASE:VCTR
|
IL |
|
D
|
Dong A Eltek Co Ltd
KOSDAQ:088130
|
KR |
|
Britannia Industries Ltd
BSE:500825
|
IN |
Relative Value
The Relative Value of one
SEZI
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 4.2 SEK,
Senzime AB (publ)
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SEZI Relative Value
HIDDEN
Multiples Across Competitors
SEZI Competitors Multiples
Senzime AB (publ) Competitors
Senzime AB (publ) Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Senzime AB (publ)
STO:SEZI
|
660.3m SEK | 6.4 | -4.9 | -6 | -4.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182B USD | 4.1 | 27.9 | 16 | 22 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.9B USD | 16.6 | 58.4 | 44.3 | 54.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD | 5 | 38.6 | 19.8 | 23.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.8B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.5B USD | 5.2 | 35.7 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.7 | 11 | 15.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD | 7.9 | 44.8 | 24.6 | 27 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.9B USD | 10.7 | 43.3 | 30.7 | 34 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.1B USD | 2.1 | 25.7 | 10.1 | 17.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
